Vitamin Shoppe Coverage Initiated by Analysts at Jefferies Group (VSI)
Stock analysts at Jefferies Group assumed coverage on shares of Vitamin Shoppe (NYSE:VSI) in a report issued on Monday, TheFlyOnTheWall.com reports. The firm set a “hold” rating and a $42.00 price target on the stock. Jefferies Group’s target price would suggest a potential downside of 3.43% from the stock’s previous close.
The analysts wrote, “We see risk of weak same store sales trends persisting into 2H13, and margins will be under pressure from the start up of a new distribution center, acquisition integration costs and entry into the Canadian market. With competitor GNC likely to widen its same store sales lead over Vitamin Shoppe as it rolls out its new Gold Card member pricing, the disparity in results between these two could keep VSI shares under pressure.”
Vitamin Shoppe (NYSE:VSI) opened at 43.49 on Monday. Vitamin Shoppe has a 52 week low of $39.92 and a 52 week high of $65.93. The stock has a 50-day moving average of $42.39 and a 200-day moving average of $45.7. The company has a market cap of $1.305 billion and a P/E ratio of 20.38.
Vitamin Shoppe (NYSE:VSI) last posted its quarterly earnings results on Tuesday, August 6th. The company reported $0.60 earnings per share for the quarter, meeting the analysts’ consensus estimate of $0.60. The company had revenue of $279.50 million for the quarter, compared to the consensus estimate of $284.28 million. During the same quarter last year, the company posted $0.55 earnings per share. Vitamin Shoppe’s revenue was up 14.1% compared to the same quarter last year.
VSI has been the subject of a number of other recent research reports. Analysts at Deutsche Bank initiated coverage on shares of Vitamin Shoppe in a research note to investors on Wednesday, September 25th. They set a “buy” rating and a $52.00 price target on the stock. Separately, analysts at Barclays Capital initiated coverage on shares of Vitamin Shoppe in a research note to investors on Tuesday, September 24th. They set an “equal weight” rating on the stock. Finally, analysts at Sterne Agee downgraded shares of Vitamin Shoppe from a “buy” rating to a “neutral” rating in a research note to investors on Friday, September 13th. They now have a $45.00 price target on the stock, down previously from $54.00. Two investment analysts have rated the stock with a sell rating, five have assigned a hold rating and ten have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average price target of $54.25.
Vitamin Shoppe, Inc is a specialty retailer and direct marketer of vitamins, minerals, herbs, specialty supplements, sports nutrition and other health and wellness products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.